Go Pro
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel Free BKYI Stock Alerts

BIO-key International (BKYI) Competitors

BIO-key International logo
$2.04 -0.45 (-18.07%)
Closing price 04:00 PM Eastern
Extended Trading
$2.04 0.00 (-0.25%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BKYI vs. AUID, ARQQW, BTQ, MSFT, and ORCL

Should you buy BIO-key International stock or one of its competitors? BIO-key International's main competitors and comparable companies include authID (AUID), Arqit Quantum (ARQQW), BTQ Technologies (BTQ), Microsoft (MSFT), and Oracle (ORCL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does BIO-key International compare to authID?

authID (NASDAQ:AUID) and BIO-key International (NASDAQ:BKYI) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

BIO-key International has higher revenue and earnings than authID. BIO-key International is trading at a lower price-to-earnings ratio than authID, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
authID$1.27M5.47-$17.93M-$1.23N/A
BIO-key International$6.09M0.48-$7.16M-$4.11N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
authID
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

BIO-key International has a net margin of -50.01% compared to authID's net margin of -934.06%. BIO-key International's return on equity of -67.31% beat authID's return on equity.

Company Net Margins Return on Equity Return on Assets
authID-934.06% -297.48% -213.83%
BIO-key International -50.01%-67.31%-40.28%

authID has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, BIO-key International has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

8.8% of authID shares are owned by institutional investors. Comparatively, 26.5% of BIO-key International shares are owned by institutional investors. 17.4% of authID shares are owned by insiders. Comparatively, 4.0% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, BIO-key International had 5 more articles in the media than authID. MarketBeat recorded 6 mentions for BIO-key International and 1 mentions for authID. authID's average media sentiment score of 0.00 beat BIO-key International's score of -0.09 indicating that authID is being referred to more favorably in the media.

Company Overall Sentiment
authID Neutral
BIO-key International Neutral

Summary

BIO-key International beats authID on 8 of the 14 factors compared between the two stocks.

How does BIO-key International compare to Arqit Quantum?

BIO-key International (NASDAQ:BKYI) and Arqit Quantum (NASDAQ:ARQQW) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Arqit Quantum
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

26.5% of BIO-key International shares are held by institutional investors. 4.0% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, BIO-key International had 6 more articles in the media than Arqit Quantum. MarketBeat recorded 6 mentions for BIO-key International and 0 mentions for Arqit Quantum. Arqit Quantum's average media sentiment score of 0.00 beat BIO-key International's score of -0.09 indicating that Arqit Quantum is being referred to more favorably in the news media.

Company Overall Sentiment
BIO-key International Neutral
Arqit Quantum Neutral

Arqit Quantum has a net margin of 0.00% compared to BIO-key International's net margin of -50.01%. Arqit Quantum's return on equity of 0.00% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Arqit Quantum N/A N/A N/A

Arqit Quantum has lower revenue, but higher earnings than BIO-key International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.48-$7.16M-$4.11N/A
Arqit Quantum$1.09MN/AN/AN/AN/A

Summary

BIO-key International beats Arqit Quantum on 5 of the 9 factors compared between the two stocks.

How does BIO-key International compare to BTQ Technologies?

BIO-key International (NASDAQ:BKYI) and BTQ Technologies (NASDAQ:BTQ) are both technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

BTQ Technologies has a net margin of 0.00% compared to BIO-key International's net margin of -50.01%. BTQ Technologies' return on equity of 0.00% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
BTQ Technologies N/A N/A N/A

26.5% of BIO-key International shares are held by institutional investors. 4.0% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, BIO-key International had 5 more articles in the media than BTQ Technologies. MarketBeat recorded 6 mentions for BIO-key International and 1 mentions for BTQ Technologies. BTQ Technologies' average media sentiment score of 0.00 beat BIO-key International's score of -0.09 indicating that BTQ Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
BIO-key International Neutral
BTQ Technologies Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
BTQ Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

BTQ Technologies has lower revenue, but higher earnings than BIO-key International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.48-$7.16M-$4.11N/A
BTQ TechnologiesN/AN/AN/AN/AN/A

Summary

BTQ Technologies beats BIO-key International on 6 of the 10 factors compared between the two stocks.

How does BIO-key International compare to Microsoft?

BIO-key International (NASDAQ:BKYI) and Microsoft (NASDAQ:MSFT) are both technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 71.1% of Microsoft shares are held by institutional investors. 4.0% of BIO-key International shares are held by company insiders. Comparatively, 0.0% of Microsoft shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Microsoft has a net margin of 40.31% compared to BIO-key International's net margin of -50.01%. Microsoft's return on equity of 31.98% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Microsoft 40.31%31.98%18.70%

Microsoft has a consensus price target of $569.29, indicating a potential upside of 14.33%. Given Microsoft's stronger consensus rating and higher probable upside, analysts clearly believe Microsoft is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Microsoft
1 Sell rating(s)
4 Hold rating(s)
43 Buy rating(s)
0 Strong Buy rating(s)
2.88

BIO-key International has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market. Comparatively, Microsoft has a beta of 1.11, indicating that its share price is 11% more volatile than the broader market.

Microsoft has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Microsoft, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.48-$7.16M-$4.11N/A
Microsoft$331.84B11.14$133.75B$17.9627.72

In the previous week, Microsoft had 241 more articles in the media than BIO-key International. MarketBeat recorded 247 mentions for Microsoft and 6 mentions for BIO-key International. Microsoft's average media sentiment score of 0.74 beat BIO-key International's score of -0.09 indicating that Microsoft is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Microsoft
119 Very Positive mention(s)
40 Positive mention(s)
45 Neutral mention(s)
29 Negative mention(s)
10 Very Negative mention(s)
Positive

Summary

Microsoft beats BIO-key International on 15 of the 16 factors compared between the two stocks.

How does BIO-key International compare to Oracle?

BIO-key International (NASDAQ:BKYI) and Oracle (NYSE:ORCL) are both technology companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Oracle has a net margin of 26.36% compared to BIO-key International's net margin of -50.01%. Oracle's return on equity of 48.85% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Oracle 26.36%48.85%7.93%

Oracle has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Oracle, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.48-$7.16M-$4.11N/A
Oracle$71.78B5.89$17.09B$6.3821.91

BIO-key International has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, Oracle has a beta of 1.74, suggesting that its stock price is 74% more volatile than the broader market.

Oracle has a consensus target price of $252.58, suggesting a potential upside of 80.72%. Given Oracle's stronger consensus rating and higher probable upside, analysts plainly believe Oracle is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Oracle
1 Sell rating(s)
8 Hold rating(s)
30 Buy rating(s)
2 Strong Buy rating(s)
2.80

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 42.4% of Oracle shares are owned by institutional investors. 4.0% of BIO-key International shares are owned by company insiders. Comparatively, 40.9% of Oracle shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Oracle had 144 more articles in the media than BIO-key International. MarketBeat recorded 150 mentions for Oracle and 6 mentions for BIO-key International. Oracle's average media sentiment score of 0.44 beat BIO-key International's score of -0.09 indicating that Oracle is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oracle
49 Very Positive mention(s)
24 Positive mention(s)
35 Neutral mention(s)
26 Negative mention(s)
12 Very Negative mention(s)
Neutral

Summary

Oracle beats BIO-key International on 17 of the 17 factors compared between the two stocks.

Get BIO-key International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BKYI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BKYI vs. The Competition

Export
MetricBIO-key InternationalSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$2.94M$15.90B$30.86B$13.10B
Dividend YieldN/A3.41%2.75%12.57%
P/E Ratio-0.50142.4779.1225.77
Price / Sales0.481,284.67586.6097.61
Price / CashN/A47.5449.7052.76
Price / Book0.438.857.986.34
Net Income-$7.16M$434.54M$702.99M$360.00M
7 Day Performance-20.62%0.35%1.21%-0.11%
1 Month Performance-31.31%-2.59%-1.32%-3.42%
1 Year Performance-73.85%-1.27%178.25%5.46%

BIO-key International Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BKYI
BIO-key International
1.3934 of 5 stars		$2.04
-18.1%		N/A-67.8%$2.94M$6.09MN/A42
AUID
authID
0.9781 of 5 stars		$0.46
-3.2%		N/A-84.8%$7.61M$2.04MN/A60
ARQQW
Arqit Quantum
N/A$0.00
flat		N/A-99.8%$0.00$1.09MN/A147
BTQ
BTQ Technologies
N/A$2.62
-0.9%		N/A-61.0%$0.00N/AN/AN/A
MSFT
Microsoft
4.799 of 5 stars		$493.73
-0.7%		$564.27
+14.3%		-1.7%$3.67T$331.84B27.49223,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BKYI) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...
American Alternative | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
NASA's ISS Replacement Could Go to This Tiny Space Firm
NASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...
Behind the Markets | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel